StreetInsider.com News Articles

Form 8-K NRX Pharmaceuticals, For: Jul 21

Wed, 22 Jul 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260722/26798048.html

Form 8-K NRX Pharmaceuticals, For: Jul 21

Wed, 22 Jul 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260722/26798048.html

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

FreeCast (NASDAQ:CAST), Big Sky Industrial (NASDAQ:BSIN), Virtuix Holdings (NASDAQ:VTIX), and Marco Polo Exchange's Steve Carlson Featuring Argentina's Capital Markets Highlight This Week's National Broadcast

NEW YORK CITY, NY / ACCESS Newswire / June 27, 2026 / New to The Street, one of the nation's longest-running business television brands, announced that Show #759 will broadcast tonight at 6:30 p.m. Eastern Time on Bloomberg Television as sponsored programming across the United States, Latin America, and the Middle East & North Africa (MENA), delivering interviews, market commentary, and investor-focused programming to a global audience.

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

Sat, 27 Jun 2026 14:40:00 -0400

Now celebrating

NRx Pharmaceuticals disputes Kadima claims amid arbitration

Thu, 25 Jun 2026 16:01:34 -0400

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) issued a statement on June 25, 2026, responding to public allegations made by Kadima Neuropsychiatry Institute regarding the non-acquisition of Kadima by HOPE Therapeutics, Inc., a majority-owned subsidiary of NRx.

NRx stated it has compelled arbitration with Kadima over the institute's claimed failure to meet key closing conditions in the transaction documents, including delivery of clear title to assets and a material adverse change in the condition of the business. The company said Kadima signed a binding arbitration agreement and entered into active arbitration.

NRx management stated it does not believe acquiring Kadima would be in the

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

Thu, 25 Jun 2026 16:01:00 -0400

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by Kadima Neuropsychiatry Institute (“Kadima”).

Kadima issued a public statement on June 24, 2026 making a series of unfounded allegations related to the non-acquisition of Kadima by HOPE Therapeutics, Inc., a majority-owned subsidiary of the Company (“HOPE”). As disclosed in recent filings with the Securities and Exchange Commission (the “SEC”), NRx has compelled arbitration with Kadima over Kadima’s failure to meet key closing conditions contemplated in

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

Thu, 25 Jun 2026 16:01:00 -0400

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

Thu, 25 Jun 2026 16:01:00 -0400

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

Thu, 25 Jun 2026 16:01:00 -0400

HOPE Therapeutics begins patient TMS treatments with Zeta navigation

Thu, 25 Jun 2026 07:00:51 -0400

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary, HOPE Therapeutics, has treated its first patients using Zeta Surgical's FDA-cleared Zeta TMS Navigation System at clinics in West Palm Beach and Sarasota, Florida.

The Zeta TMS Navigation System uses Zeta Surgical's RealTrack™ technology to provide real-time, markerless image guidance for transcranial magnetic stimulation (TMS) procedures. The system applies artificial intelligence and computer vision to register a patient's MRI or CT imaging to their facial anatomy in under two minutes and continuously tracks the TMS coil position relative to a planned brain target with sub-millimetric accuracy.

HOPE is using the system in outpatient TMS

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Thu, 25 Jun 2026 07:00:00 -0400

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and Sarasota, Florida, marking the transition from research deployment to active patient care
AI-powered, sub-millimetric image guidance is now being applied in HOPE's outpatient TMS workflows for patients with Major Depressive Disorder and other CNS conditions
Milestone advances HOPE's interventional psychiatry platform and aligns with NRx's planned trial of NRX-101 in combination with robotic-enabled TMS in civilian and military treatment facilities (the SPARC-TMS trial).

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx"